Peter M. Wehmeier

Neuropsychological Outcomes Across the Day in Children with Attention-Deficit/Hyperactivity Disorder Treated with Atomoxetine: Results from a Placebo-Controlled Study Using a Computer-Based Continuous Performance Test Combined with an Infra-Red Motion-tracking Device

Peter M. Wehmeier, Alexander Schacht, Christian Wolff et al. · Journal of Child and Adolescent Psychopharmacology · 2011 · 52 citations

Attention-deficit/hyperactivity Disorder Treated, Neuropsychology, Psychotropic Medication +19

Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study

Peter M. Wehmeier, Tobias Banaschewski · ADHD Attention Deficit and Hyperactivity Disorders · 2014 · 43 citations

Adhd Medication, Adhd, Psychiatry +10

Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetine

Esther Sobanski, D. Sabljic, Barbara Alm et al. · European Psychiatry · 2012 · 40 citations

Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day

Peter M. Wehmeier, Alexander Schacht, Manfred Döpfner · Child and Adolescent Psychiatry and Mental Health · 2008 · 30 citations · Full text

Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?

Peter M. Wehmeier, Alexander Schacht, Fredrik Ulberstad et al. · Journal of Clinical Psychopharmacology · 2012 · 30 citations

Psychotropic Medication, Psychopharmacology, Social Sciences +16